logo
Sign in

MEDXF Stock Price, Chart, Stats & News

Medexus Pharmaceuticals Inc.
Save

Medexus Pharmaceuticals Inc. (MEDXF) does not currently pay a dividend.

114.77M
Market cap
–
Current P/E
23.36x
Forward P/E

MEDXF chart

About

Health care
Sector
Medical - Pharmaceuticals
Industry

Medexus Pharmaceuticals Inc. is a specialized pharmaceutical firm conducting operations across both Canada and the United States. The company's therapeutic focus spans several critical domains, including cancer treatment (oncology), blood disorders (hematology), joint and muscle conditions (rheumatology), autoimmune disorders, and allergic reactions. Among its leading offerings are Rasuvo and Metoject, both methotrexate formulations specifically developed for managing rheumatoid arthritis and various autoimmune conditions.

Similar securities

Based on sector and market capitalization

Report issue